UNSPSC 51111849: Fosfestrol

This classification denotes a hormonal antineoplastic agent with the molecular formula C18H22O8P2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A0E0NMA80F, chemically known as 4,4-stilbenediol, .alpha., .alpha.-diethyl-, diphosphate, disodium salt but generally known as fosfestrol, which bears US NIH Compound Identifier 3032325. European Medicines Agency schedules Fosfestrol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07795MIG.

UNSPSC 51111849 Fosfestrol is a Commodity code for a synthetic estrogen pharmaceutical used in veterinary and human oncology contexts, though state and local government procurement activity under this code is minimal. The source provides no recent state or local solicitations, RFPs, RFQs, IFBs, or ITBs tagged to this code. Fosfestrol procurement, when it occurs in the public sector, is typically handled through standing pharmaceutical contracts managed by state health departments, correctional health services, or veterinary licensing boards rather than as discrete solicitations. Without access to records of active opportunities, no representative recent transactions, issuing-body patterns, or geographic concentration can be identified at this time.